Navigation Links
FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
Date:9/3/2007

Highly Successful Collaboration With CDC to Ensure US's Preparedness

Against the Threat of a Smallpox-Related Public Health Emergency

CAMBRIDGE, England and CAMBRIDGE, Massachusetts, September 3 /PRNewswire-FirstCall/ -- Acambis plc (Acambis) (LSE: ACM), a leading vaccine company, announced today that the US Food and Drug Administration (FDA) has approved its ACAM2000 (Smallpox (Vaccinia) Vaccine, Live) vaccine for protection against smallpox. The vaccine is intended for active immunization against smallpox disease for persons determined to be at high risk for smallpox infection. ACAM2000 is the first biodefense vaccine to be approved as part of the US response to the 2001 bioterrorism attacks.

Acambis developed ACAM2000 under contracts with the US Centers for Disease Control and Prevention (CDC). To date, Acambis has supplied 192.5 million doses of ACAM2000 to the CDC for the US Strategic National Stockpile (SNS), which was established to provide medicines to the American public in the event of a public health emergency, such as a terrorist attack.

Having produced a stockpile of ACAM2000 doses for the SNS, Acambis and the CDC are now in advanced discussions on a "warm-base manufacturing" contract for Acambis to provide ACAM2000 production and license maintenance activities for the long term.

Ian Garland, Acambis Chief Executive Officer, said: "The licensure of ACAM2000 is a significant milestone not only for Acambis but also for the US Government in its efforts to ensure a state of preparedness against the threat of smallpox. This has been a highly successful collaboration between Acambis and the CDC, and Acambis is very proud to have played a role in providing this countermeasure against a significant bioterrorism threat. We look forward to finalizing an agreement with the CDC that will ensure that a US-based capability to manufacture ACAM2000 remains at the ready."

ACAM2000 was developed to be a modern smallpox vaccin
'/>"/>

SOURCE Acambis plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. UW-Madison approves new research institute
2. FDA approves GEs heart-imaging technology
3. Senate approves bill to expand stem cell funding
4. FDA approves advanced digital mammography system
5. Building commission approves Institutes for Discovery
6. UW Board of Regents approves $134 million medical research facility
7. FDA approves Bone Cares Hectorol for treatment of kidney disease
8. New Mexico firm to make flu vaccine at Wisconsin BioManufacturing facility
9. Studies Offer New Insight into HIV Vaccine Development
10. Protector RNase Inhibitor Enhance the Protection of RNA against Degradation
11. RNase Protection Assay (RPA) Using DIG-Labeled RNA Probes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Can economic incentives such as ... members of the public to increase their donations of ... Hopkins Carey Business School Assistant Professor Mario Macis ... a large body of recent research that supports their ... 2013, issue of Science that the World Health Organization ...
(Date:5/23/2013)... Wis. , May 23, 2013 ... researcher, developer, and marketer of over-the-counter (OTC) medicinal ... its research opinion on the company based on ... , Non-Prescription, All Natural Product to ... the Product Outperforms #1 Prescription Competitor , ...
(Date:5/23/2013)... PI’s new LPS-24 positioners are less ... travel range with closed-loop sensor resolution up to ... new positioners the ideal choice for high precision ... is also available. , More Information: Specifications ... found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 , Reference-Class ...
(Date:5/23/2013)... MENLO PARK, Calif. , May 23, 2013 /PRNewswire/ ... an oral treatment for pain has reached an important ... clinical trial of VBY-036 - a selective cathepsin S ... of VBY-036 is a double-blind, randomized, placebo-controlled study designed ... escalating doses of VBY-036 in healthy adults. ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
... Vascular,Inc. (Nasdaq: LMAT ) (the "Company") today announced ... of Directors, effective as of January 1,2008. Mr. Hays ... election at,the next annual meeting of the Company,s shareholders, ... and Corporate Governance Committee and,as a member of its ...
... Pilot Chevrolet Car, VALLEY FORGE, Pa., Dec. 17 ... joined with Diversified Racing Solutions,(DRS) to enter the NASCAR(R) ... the NASCAR Sprint Cup Series in 2010. In the ... the flagship,sponsor; the venture will be primarily funded by ...
... Holding, Inc. (Other OTC: NHGI) today announced that ... are,posted on the OTCIQ, a service of the ... portal that provides issuers access to,innovative products and ... mitigate risk, gather market,intelligence, and inspire better corporate ...
Cached Biology Technology:LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors 2Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008 2National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC 2
(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...
(Date:5/23/2013)... succeeded in treating cerebral palsy with autologous cord blood. ... 2.5 year old boy had been in a persistent ... two months after treatment with the cord blood containing ... months, the child learned to speak simple sentences and ... Korean study, dispel the long-held doubts about the effectiveness ...
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes ... the TKF Foundation, will examine how collaborative planning and ... from tragedy. , The TKF Foundation announced today that ... for grant funding. In addition to research on the ... and resiliency, the 3-year, $585,000 grant will contribute to ...
Breaking Biology News(10 mins):UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2First successful treatment of pediatric cerebral palsy with autologous cord blood 2'Landscapes of Resilience' to study how people use nature as a source of recovery 2
... RIDGE, Tenn., June 15, 2011 A first of ... Department of Energy,s Oak Ridge National Laboratory is providing ... biofuels. , Lignin, a major component of plant cell ... the production of cellulosic ethanol. The exact shape and ...
... A long-term study verifies multi-paddock grazing improves ... continuous grazing in large-scale ranches, according to Texas ... impacts on vegetation and soils achieved by commercial ... to changing circumstances to achieve desirable outcomes, said ...
... International and American Associations for Dental Research (IADR/AADR) have ... and Pulp Regeneration," held in Geneva, Switzerland, July 2010. ... and Regeneration Group, and they are published in volume ... an E-supplement to the Journal of Dental Research ...
Cached Biology News:ORNL neutrons, simulations reveal details of bioenergy barrier 2AgriLife research: Multi-paddock grazing is superior to continuous grazing 2AgriLife research: Multi-paddock grazing is superior to continuous grazing 3AgriLife research: Multi-paddock grazing is superior to continuous grazing 4IADR/AADR publish proceedings from Symposium on Tissue Injury and Pulp Regeneration 2
...
...
... Experion software, PC, is used to ... data obtained from the Experion automated ... in electropherogram and simulated gel views ... calculations in a Results table. This ...
... for use in the Microsart e.motion are sterile-sealed, ... in a specially designed individual package on a ... band of membrane filter units ensures that they ... the sealed band guarantees uniform dispensing of the ...
Biology Products: